Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)

ClinicalTrials.gov ID: NCT03428646

Public ClinicalTrials.gov record NCT03428646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 3:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective Observational Study of Patients Receiving DUPIXENT® for Atopic Dermatitis

Study identification

NCT ID
NCT03428646
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
858 participants

Conditions and interventions

Interventions

  • Dupilumab Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 5, 2018
Primary completion
Mar 29, 2027
Completion
Mar 29, 2027
Last update posted
Dec 28, 2025

2018 – 2027

United States locations

U.S. sites
93
U.S. states
28
U.S. cities
86
Facility City State ZIP Site status
Regeneron Investigational Site Birmingham Alabama 35205
Regeneron Investigational Site Gilbert Arizona 85234
Regeneron Investigational Site Fountain Valley California 92708
Regeneron Investigational Site Laguna Hills California 92653
Regeneron Investigational Site Loma Linda California 92354
Regeneron Investigational Site Los Angeles California 90025
Regeneron Investigational Site Los Angeles California 90067
Regeneron Investigational Site Manhattan Beach California 90266-2911
Regeneron Investigational Site Newport Beach California 92663
Regeneron Investigational Site Oceanside California 92056
Regeneron Investigational Site Redondo Beach California 90277
Regeneron Investigational Site Riverside California 92506-0174
Regeneron Investigational Site Roseville California 95661
Regeneron Investigational Site San Diego California 92123
Regeneron Investigational Site Santa Monica California 90404
Regeneron Investigational Site Thousand Oaks California 91320
Regeneron Investigational Site New Haven Connecticut 06519
Regeneron Investigational Site Coral Gables Florida 33146
Regeneron Investigational Site Margate Florida 33063
Regeneron Investigational Site West Palm Beach Florida 33406
Regeneron Investigational Site Atlanta Georgia 30342-1703
Regeneron Investigational Site Macon Georgia 31217
Regeneron Investigational Site Marietta Georgia 30060-1047
Regeneron Investigational Site Marietta Georgia 30152
Regeneron Investigational Site Sandy Springs Georgia 30328
Regeneron Investigational Site Champaign Illinois 61820
Regeneron Investigational Site Chicago Illinois 60654
Regeneron Investigational Site La Grange Park Illinois 60526
Regeneron Investigational Site Skokie Illinois 60077
Regeneron Investigational Site Springfield Illinois 62604
Regeneron Investigational Site Fort Wayne Indiana 46804
Regeneron Investigational Site Plainfield Indiana 46168
Regeneron Investigational Site Overland Park Kansas 66215
Regeneron Investigational Site Corbin Kentucky 40701
Regeneron Investigational Site Louisville Kentucky 40202
Regeneron Investigational Site Rockville Maryland 20850
Regeneron Investigational Site Towson Maryland 21204
Regeneron Investigational Site Upper Marlboro Maryland 20772
Regeneron Investigational Site White Marsh Maryland 21162
Regeneron Investigational Site Quincy Massachusetts 02169
Regeneron Investigational Site Ann Arbor Michigan 48103
Regeneron Investigational Site Bay City Michigan 48706
Regeneron Investigational Site Troy Michigan 48084
Regeneron Investigational Site Warren Michigan 48088
Regeneron Investigational Site Columbia Missouri 65212-0001
Regeneron Investigational Site Kirksville Missouri 63501
Regeneron Investigational Site St Louis Missouri 63110
Regeneron Investigational Site Lincoln Nebraska 68505
Regeneron Investigational Site Henderson Nevada 89052
Regeneron Investigational Site Las Vegas Nevada 89144
Regeneron Investigational Site Brick New Jersey 08724
Regeneron Investigational Site East Windsor New Jersey 08520
Regeneron Investigational Site Edison New Jersey 08820
Regeneron Investigational Site Piscataway New Jersey 08854
Regeneron Investigational Site Elmhurst New York 11373-4831
Regeneron Investigational Site Forest Hills New York 11374
Regeneron Investigational Site Garden City New York 11530
Regeneron Investigational Site Kew Gardens New York 11374
Regeneron Investigational Site Lake Success New York 11042
Regeneron Investigational Site Manhasset New York 11030
Regeneron Investigational Site Mineola New York 11501
Regeneron Investigational Site Mount Vernon New York 10552
Regeneron Investigational Site New York New York 10012-1354
Regeneron Investigational Site New York New York 10016
Regeneron Investigational Site New York New York 10029
Regeneron Investigational Site New York New York 10075
Regeneron Investigational Site The Bronx New York 10467-2401
Regeneron Investigational Site Troy New York 12180
Regeneron Investigational Site Concord North Carolina 28025
Regeneron Investigational Site Akron Ohio 44333
Regeneron Investigational Site Athens Ohio 45701
Regeneron Investigational Site Bexley Ohio 43209
Regeneron Investigational Site Marion Ohio 43302
Regeneron Investigational Site Mason Ohio 45040
Regeneron Investigational Site Tulsa Oklahoma 74136
Regeneron Investigational Site Portland Oregon 97239
Regeneron Investigational Site Blue Bell Pennsylvania 19422
Regeneron Investigational Site Philadelphia Pennsylvania 19107
Regeneron Investigational Site Philadelphia Pennsylvania 19140
Regeneron Investigational Site Sellersville Pennsylvania 18960
Regeneron Investigational Site Yardley Pennsylvania 19067
Regeneron Investigational Site Charleston South Carolina 29425
Regeneron Investigational Site North Charleston South Carolina 29420-4211
Regeneron Investigational Site Bellaire Texas 77401
Regeneron Investigational Site Dallas Texas 75231
Regeneron Investigational Site Grapevine Texas 76051
Regeneron Investigational Site San Antonio Texas 78205
Regeneron Investigational Site Sugar Land Texas 77478
Regeneron Investigational Site Sugar Land Texas 77479
Regeneron Investigational Site Arlington Virginia 22204
Regeneron Investigational Site Norfolk Virginia 23502
Regeneron Investigational Site Bellevue Washington 98004
Regeneron Investigational Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03428646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 28, 2025 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03428646 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →